Metabolic Syndrome Resolved within Two Years is Still a Risk Factor for Kidney Cancer

The prevalence of metabolic syndrome (MetS) and kidney cancer is increasing, but studies on the effects of MetS and its components on kidney cancer development have had ambiguous results. Overall, 7,613,865 patients from the Korean National Health Insurance System were analyzed and followed up until...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Tae Ryom, Han, Kyung-Do, Choi, Hong Sang, Kim, Chang Seong, Bae, Eun Hui, Ma, Seong Kwon, Kim, Soo Wan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780562/
https://www.ncbi.nlm.nih.gov/pubmed/31466366
http://dx.doi.org/10.3390/jcm8091329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780562/
https://www.ncbi.nlm.nih.gov/pubmed/31466366
http://dx.doi.org/10.3390/jcm8091329

Ejemplares similares